Concordance of somatic mutation profiles (BRAF, NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 82, 206-214
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanomaJournal of Translational Medicine, 2013
- Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular TestingPLOS ONE, 2013
- Frequency of TERT promoter mutations in human cancersNature Communications, 2013
- Highly Recurrent TERT Promoter Mutations in Human MelanomaScience, 2013
- TERT Promoter Mutations in Familial and Sporadic MelanomaScience, 2013
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune EscapeScience Translational Medicine, 2012
- Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic MelanomaPLOS ONE, 2012
- BRAF mutations in cutaneous melanoma: no correlation with histological prognostic factors or overall survivalJornal Brasileiro de Patologia e Medicina Laboratorial, 2010
- Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanomaCancer, 2010
- Mutations of the BRAF gene in human cancerNature, 2002